Infección viral respiratoria nosocomial
DOI:
https://doi.org/10.23938/ASSN.0344Palabras clave:
Infección viral respiratoria nosocomial.Resumen
Las infecciones virales nosocomiales han sido objeto de pocos estudios. En este contexto, el objetivo de este trabajo es revisar los datos epidemiológicos y terapéuticos publicados sobre los principales agentes virales productores de infección nosocomial respiratoria. De este modo se pretende ampliar el conocimiento sobre el comportamiento de estos agentes en las infecciones nosocomiales y proporcionar información para mejorar la aplicación de las medidas de prevención. De manera pormenorizada se exponen conceptos relativos a los mimivirus, virus herpes simple, virus varicela-zóster, citomegalovirus, virus respiratorio sincitial, virus parainfluenza, virus de la gripe, adenovirus, metapneumovirus y virus del sarampión.
Descargas
Citas
1. GARCIA-CENOZ M, CHAMORRO J, VIDAN J, LANZETA I, LAMEIRO F, URTASUN JM et al. Prevalencia de la infección nosocomial en Navarra. Resultados agregados del estudio EPINE 2005. An Sist Sanit Navar 2007; 30: 89-99.
https://doi.org/10.4321/S1137-66272007000100009
2. BERMEJO B, GARCÍA DE JALÓN J, INSAUSTI J. Vigilancia y control de las infecciones nosocomiales: EPINE, VICONOS, PREVINE, ENVIN-UCI. An Sist Sanit Navar 2000; 23 (Suplem. 2) : 37-47.
3. HOLLADAY RC, CAMPBELL GD, JR. Nosocomial viral pneumonia in the intensive care unit. Clin Chest Med 1995; 16: 121-133.
https://doi.org/10.1016/S0272-5231(21)00982-5
4. ANDERSON LJ. Major trends in nosocomial viral infections. Am J Med 1991 16; 91: 107S-111S.
https://doi.org/10.1016/0002-9343(91)90353-Y
5. LA SCOLA B, AUDIC S, ROBERT C, JUNGANG L, DE LAMBALLERIE X, DRANCOURT M et al. A giant virus in amoebae. Science 2003; 299: 2033.
https://doi.org/10.1126/science.1081867
6. BIRTLES RJ, ROWBOTHAM TJ, STOREY C, MARRIE TJ, RAOULT D. Chlamydia-like obligate parasite of free-living amoebae. Lancet 1997; 349: 925-926.
https://doi.org/10.1016/S0140-6736(05)62701-8
7. BERGER P, PAPAZIAN L, DRANCOURT M, LA SCOLA B, AUFFRAY JP, RAOULT D. Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis 2006; 12: 248-255.
https://doi.org/10.3201/eid1202.050434
8. LA SCOLA B, MEZI L, AUFFRAY JP, BERLAND Y, RAOULT D. Patients in the intensive care unit are exposed to amoeba-associated pathogens. Infect Control Hosp Epidemiol 2002; 23: 462-465.
https://doi.org/10.1086/502086
9. VINCENT A, LA SCOLA B, FOREL JM, PAULY V, RAOULT D, PAPAZIAN L. Clinical significance of a positive serology for mimivirus in patients presenting a suspicion of ventilator-associated pneumonia. Crit Care Med 2009; 37: 111-118.
https://doi.org/10.1097/CCM.0b013e318192fa8b
10. RUTALA WA, WEBER DJ. Water as a reservoir of nosocomial pathogens. Infect Control Hosp Epidemiol 1997; 18: 609-616.
https://doi.org/10.1086/502237
11. WALOCHNIK J, PICHER O, ASPOCK C, ULLMANN M, SOMMER R, ASPOCK H. Interactions of "Limax amoebae" and gram-negative bacteria: experimental studies and review of current problems. Tokai J Exp Clin Med 1998; 23: 273-278.
12. ANAISSIE EJ, PENZAK SR, DIGNANI MC. The hospital water supply as a source of nosocomial infections: a plea for action. Arch Intern Med 2002; 162: 1483-1492.
https://doi.org/10.1001/archinte.162.13.1483
13. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49: 1-125, CE1-7.
14. VINCENT A, LA SCOLA B, PAPAZIAN L. Advances in Mimivirus pathogenicity. Intervirology 2010; 53: 304-309.
https://doi.org/10.1159/000312915
15. AITKEN C, JEFFRIES DJ. Nosocomial spread of viral disease. Clin Microbiol Rev 2001; 14: 528-546.
https://doi.org/10.1128/CMR.14.3.528-546.2001
16. CHICHE L, FOREL JM, PAPAZIAN L. The role of viruses in nosocomial pneumonia. Curr Opin Infect Dis 2011; 24: 152-156.
https://doi.org/10.1097/QCO.0b013e328343b6e4
17. BRUYNSEELS P, JORENS PG, DEMEY HE, GOOSSENS H, PATTYN SR, ELSEVIERS MM et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 2003; 362: 1536-1541.
https://doi.org/10.1016/S0140-6736(03)14740-X
18. MOHAN S, HAMID NS, CUNHA BA. A cluster of nosocomial herpes simplex virus type 1 pneumonia in a medical intensive care unit. Infect Control Hosp Epidemiol 2006; 27: 1255-1257.
https://doi.org/10.1086/508843
19. PAPAZIAN L, DODDOLI C, CHETAILLE B, GERNEZ Y, THIRION X, ROCH A et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007; 35: 755-762.
https://doi.org/10.1097/01.CCM.0000257325.88144.30
20. RAMSEY PG, FIFE KH, HACKMAN RC, MEYERS JD, COREY L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 1982; 97: 813-820.
https://doi.org/10.7326/0003-4819-97-6-813
21. LUYT CE, COMBES A, DEBACK C, AUBRIOT-LORTON MH, NIESZKOWSKA A, TROUILLET JL et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175: 935-942.
https://doi.org/10.1164/rccm.200609-1322OC
22. LUYT CE, COMBES A, NIESZKOWSKA A, TROUILLET JL, CHASTRE J. VIRAL infections in the ICU. Curr Opin Crit Care 2008; 14: 605-608.
https://doi.org/10.1097/MCC.0b013e32830f1e12
23. OUD L. Comment on: "Nosocomial viral ventilator-associated pneumonia in the intensive care unit" by Daubin et al. Intensive Care Med 2006; 32: 613; author reply 614-615.
https://doi.org/10.1007/s00134-005-0035-z
24. TUXEN DV, CADE JF, MCDONALD MI, BUCHANAN MR, CLARK RJ, PAIN MC. Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis 1982; 126: 416-419.
25. DE VOS N, VAN HOOVELS L, VANKEERBERGHEN A, VAN VAERENBERGH K, BOEL A, DEMEYER I et al. Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: a prospective study. Clin Microbiol Infect 2009; 15: 358-363.
https://doi.org/10.1111/j.1469-0691.2009.02704.x
26. LINSSEN CF, JACOBS JA, STELMA FF, VAN MOOK WN, TERPORTEN P, VINK C et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med 2008; 34: 2202-2209.
https://doi.org/10.1007/s00134-008-1231-4
27. ONG GM, LOWRY K, MAHAJAN S, WYATT DE, SIMPSON C, O'NEILL HJ et al. Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. J Med Virol 2004; 72: 121-125.
https://doi.org/10.1002/jmv.10524
28. GRAHAM BS, SNELL JD, JR. Herpes simplex virus infection of the adult lower respiratory tract. Medicine (Baltimore) 1983; 62: 384-393.
https://doi.org/10.1097/00005792-198311000-00004
29. COOK CH, MARTIN LC, YENCHAR JK, LAHM MC, MCGUINNESS B, DAVIES EA et al. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003; 31: 1923-1929.
https://doi.org/10.1097/01.CCM.0000070222.11325.C4
30. SCHEITHAUER S, MANEMANN AK, KRUGER S, HAUSLER M, KRUTTGEN A, LEMMEN SW et al. Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection 2010; 38: 401-405.
https://doi.org/10.1007/s15010-010-0036-x
31. CAMPS K, JORENS PG, DEMEY HE, PATTYN SR, IEVEN M. Clinical significance of herpes simplex virus in the lower respiratory tract of critically ill patients. Eur J Clin Microbiol Infect Dis 2002; 21: 758-759.
https://doi.org/10.1007/s10096-002-0809-y
32. HEROUT V, VORTEL V, VONDRACKOVA A. Herpes simplex involvement of the lower respiratory tract. Am J Clin Pathol 1966; 46: 411-419.
https://doi.org/10.1093/ajcp/46.4.411
33. ASANO Y, IWAYAMA S, MIYATA T, YAZAKI T, OZAKI T, TSUZUKI K et al. Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine. Biken J 1980; 23: 157-161.
34. YOSHIKAWA T, IHIRA M, SUZUKI K, SUGA S, TOMITAKA A, UEDA H et al. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster. J Med Virol 2001; 63: 64-66.
https://doi.org/10.1002/1096-9071(200101)63:1<64::AID-JMV1009>3.0.CO;2-6
35. MEHTA SK, TYRING SK, GILDEN DH, COHRS RJ, LEAL MJ, CASTRO VA et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis 2008; 197: 654-657.
https://doi.org/10.1086/527420
36. PARKER SP, QUINLIVAN M, TAHA Y, BREUER J. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Microbiol 2006; 44: 3911-3914.
https://doi.org/10.1128/JCM.00346-06
37. NAGASAKO EM, JOHNSON RW, GRIFFIN DR, DWORKIN RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 2002; 46: 834-839.
https://doi.org/10.1067/mjd.2002.120924
38. BREUER J. Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission. J Infect Dis 2008; 197: 635-637.
https://doi.org/10.1086/527421
39. LOPEZ AS, BURNETT-HARTMAN A, NAMBIAR R, RITZ L, OWENS P, LOPAREV VN et al. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008; 197: 646-653.
https://doi.org/10.1086/527419
40. SUZUKI K, YOSHIKAWA T, TOMITAKA A, MATSUNAGA K, ASANO Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004; 189: 1009-1012.
https://doi.org/10.1086/382029
41. WREGHITT TG, WHIPP J, REDPATH C, HOLLINGWORTH W. An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987-1992. Epidemiol Infect 1996; 117: 165-171.
https://doi.org/10.1017/S0950268800001278
42. OXMAN MN, LEVIN MJ, JOHNSON GR, SCHMADER KE, STRAUS SE, GELB LD et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 ; 352: 2271-2284.
https://doi.org/10.1056/NEJMoa051016
43. DWORKIN RH, JOHNSON RW, BREUER J, GNANN JW, LEVIN MJ, BACKONJA M et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44 (Suppl 1): S1-26.
https://doi.org/10.1086/510206
44. YEAGER AS. Longitudinal, serological study of cytomegalovirus infections in nurses and in personnel without patient contact. J Clin Microbiol 1975; 2: 448-452.
https://doi.org/10.1128/jcm.2.5.448-452.1975
45. DEMMLER GJ, YOW MD, SPECTOR SA, REIS SG, BRADY MT, ANDERSON DC et al. Nosocomial cytomegalovirus infections within two hospitals caring for infants and children. J Infect Dis 1987; 156: 9-16.
https://doi.org/10.1093/infdis/156.1.9
46. BALTHESEN M, MESSERLE M, REDDEHASE MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67: 5360-5366.
https://doi.org/10.1128/jvi.67.9.5360-5366.1993
47. JOOS L, CHHAJED PN, WALLNER J, BATTEGAY M, STEIGER J, GRATWOHL A et al. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007; 101: 93-97.
https://doi.org/10.1016/j.rmed.2006.04.006
48. KALIL AC, FLORESCU DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009; 37: 2350-2358.
https://doi.org/10.1097/CCM.0b013e3181a3aa43
49. CHICHE L, FOREL JM, ROCH A, GUERVILLY C, PAULY V, ALLARDET-SERVENT J et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009; 37: 1850-1857.
https://doi.org/10.1097/CCM.0b013e31819ffea6
50. CRUMPACKER CS, WADHWA S. Capítulo 134: Citomegalovirus. Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 6th ed. Philadelphia: Churchill Livingstone Elsevier; 2007, p. 1786-1801.
51. GRAMAN PS, HALL CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin North Am 1989; 3: 815-841.
https://doi.org/10.1016/S0891-5520(20)30309-3
52. GROOTHUIS JR, SIMOES EA, LEVIN MJ, HALL CB, LONG CE, RODRIGUEZ WJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 1993; 329: 1524-1530.
https://doi.org/10.1056/NEJM199311183292102
53. HALL CB, DOUGLAS RG, JR, GEIMAN JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 1975; 132: 151-156.
https://doi.org/10.1093/infdis/132.2.151
54. ADAMS R, CHRISTENSON J, PETERSEN F, BEATTY P. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone Marrow Transplant 1999; 24: 661-664.
https://doi.org/10.1038/sj.bmt.1701959
55. KASSIS C, CHAMPLIN RE, HACHEM RY, HOSING C, TARRAND JJ, PEREGO CA et al. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant 2010; 16: 1265-1271.
https://doi.org/10.1016/j.bbmt.2010.03.011
56. BONT L. Nosocomial RSV infection control and outbreak management. Paediatr Respir Rev 2009; 1: 16-17.
https://doi.org/10.1016/S1526-0542(09)70008-9
57. HALL CB. The shedding and spreading of respiratory syncytial virus. Pediatr Res 1977; 11: 236-239.
https://doi.org/10.1203/00006450-197704000-00397
58. HART RJ. An outbreak of respiratory syncytial virus infection in an old people's home. J Infect 1984; 8: 259-261.
https://doi.org/10.1016/S0163-4453(84)94075-1
59. HALL CB, DOUGLAS RG, JR, GEIMAN JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980; 141: 98-102.
https://doi.org/10.1093/infdis/141.1.98
60. HALL CB, DOUGLAS RG, JR. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99: 100-103.
https://doi.org/10.1016/S0022-3476(81)80969-9
61. GREENBERG SB. Viral pneumonia. Infect Dis Clin North Am 1991; 5: 603-621.
https://doi.org/10.1016/S0891-5520(20)30408-6
62. ENGLUND JA, SULLIVAN CJ, JORDAN MC, DEHNER LP, VERCELLOTTI GM, BALFOUR HH, JR. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988 1; 109: 203-208.
https://doi.org/10.7326/0003-4819-109-3-203
63. ZAROUKIAN MH, LEADER I. Community-acquired pneumonia and infection with respiratory syncytial virus. Ann Intern Med 1988; 109: 515-516.
https://doi.org/10.7326/0003-4819-109-6-515
64. GUIDRY GG, BLACK-PAYNE CA, PAYNE DK, JAMISON RM, GEORGE RB, BOCCHINI JA, JR. Respiratory syncytial virus infection among intubated adults in a University Medical Intensive Care Unit. Chest 1991; 100: 1377-1384.
https://doi.org/10.1378/chest.100.5.1377
65. TAKIMOTO CH, CRAM DL, ROOT RK. Respiratory syncytial virus infections on an adult medical ward. Arch Intern Med 1991; 151: 706-708.
https://doi.org/10.1001/archinte.1991.00400040058013
66. SABLE CA, HAYDEN FG. Orthomyxoviral and paramyxoviral infections in transplant patients. Infect Dis Clin North Am 1995; 9: 987-1003.
https://doi.org/10.1016/S0891-5520(20)30712-1
67. WENDT CH, HERTZ MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect 1995; 10: 224-231.
68. WHIMBEY E, CHAMPLIN RE, COUCH RB, ENGLUND JA, GOODRICH JM, RAAD I et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-782.
https://doi.org/10.1093/clinids/22.5.778
69. GALA CL, HALL CB, SCHNABEL KC, PINCUS PH, BLOSSOM P, HILDRETH SW et al. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 1986; 256: 2706-2708.
https://doi.org/10.1001/jama.1986.03380190076028
70. LECLAIR JM, FREEMAN J, SULLIVAN BF, CROWLEY CM, GOLDMANN DA. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987; 317: 329-334.
https://doi.org/10.1056/NEJM198708063170601
71. TABLAN OC, ANDERSON LJ, BESSER R, BRIDGES C, HAJJEH R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53: 1-36.
72. MEISSNER HC, WELLIVER RC, CHARTRAND SA, LAW BJ, WEISMAN LE, DORKIN HL et al. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J 1999; 18: 223-231.
https://doi.org/10.1097/00006454-199903000-00004
73. WHIMBEY E, ENGLUND JA, COUCH RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997; 102: 10-8; discussion 25-26.
https://doi.org/10.1016/S0002-9343(97)80004-6
74. GHOSH S, CHAMPLIN RE, ENGLUND J, GIRALT SA, ROLSTON K, RAAD I et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751-755.
https://doi.org/10.1038/sj.bmt.1702228
75. CHEMALY RF, GHOSH S, BODEY GP, ROHATGI N, SAFDAR A, KEATING MJ et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85: 278-287.
https://doi.org/10.1097/01.md.0000232560.22098.4e
76. American Academy of Pediatrics Committee on Infectious Diseases: Ribavirin therapy of respiratory syncytial virus. Pediatrics 1987; 79: 475-478.
https://doi.org/10.1542/peds.79.3.475
77. GARNER JS, SIMMONS BP. Guideline for isolation precautions in hospitals. Infect Control 1983; 4: 245-325.
78. LAURICHESSE H, DEDMAN D, WATSON JM, ZAMBON MC. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol 1999; 15: 475-484.
https://doi.org/10.1023/A:1007511018330
79. WENDT CH, WEISDORF DJ, JORDAN MC, BALFOUR HH, JR., HERTZ MI. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 1992; 326: 921-926.
https://doi.org/10.1056/NEJM199204023261404
80. AVADHANULA V, RODRIGUEZ CA, DEVINCENZO JP, WANG Y, WEBBY RJ, ULETT GC et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 2006; 80: 1629-1636.
https://doi.org/10.1128/JVI.80.4.1629-1636.2006
81. HARVALA H, GAUNT E, MCINTYRE C, RODDIE H, LABONTE S, CURRAN E et al. Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit. J Infect 2012; 65: 246-254.
https://doi.org/10.1016/j.jinf.2012.04.011
82. BRADY MT, EVANS J, CUARTAS J. Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 1990; 18: 18-23.
https://doi.org/10.1016/0196-6553(90)90206-8
83. LEE AV, BIBBY DF, OAKERVEE H, ROHATINER A, USHIRO-LUMB I, CLARK DA et al. Nosocomial transmission of parainfluenza 3 virus in hematological patients characterized by molecular epidemiology. Transpl Infect Dis 2011; 13: 433-437.
https://doi.org/10.1111/j.1399-3062.2011.00603.x
84. JALAL H, BIBBY DF, BENNETT J, SAMPSON RE, BRINK NS, MACKINNON S et al. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol 2007; 45: 1690-1696.
https://doi.org/10.1128/JCM.01912-06
85. LEWIS VA, CHAMPLIN R, ENGLUND J, COUCH R, GOODRICH JM, ROLSTON K et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996; 23: 1033-1037.
https://doi.org/10.1093/clinids/23.5.1033
86. COBIAN L, HOUSTON S, GREENE J, SINNOTT JT. Parainfluenza virus respiratory infection after heart transplantation: successful treatment with ribavirin. Clin Infect Dis 1995; 21: 1040-1041.
https://doi.org/10.1093/clinids/21.4.1040
87. MALAVAUD S, MALAVAUD B, SANDRES K, DURAND D, MARTY N, ICART J et al. Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department. Transplantation 2001; 72: 535-537.
https://doi.org/10.1097/00007890-200108150-00032
88. V D HOEVEN AM, SCHOLING M, WEVER PC, FIJNHEER R, HERMANS M, SCHNEEBERGER PM. Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection 2007; 35: 65-68.
https://doi.org/10.1007/s15010-007-6112-1
89. WEINGARTEN S, FRIEDLANDER M, RASCON D, AULT M, MORGAN M, MEYER RD. Influenza surveillance in an acute-care hospital. Arch Intern Med 1988; 148: 113-116.
https://doi.org/10.1001/archinte.1988.00380010117011
90. COUCH RB, ENGLUND JA, WHIMBEY E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102: 2-9; discussion 25-26.
https://doi.org/10.1016/S0002-9343(97)00003-X
91. HORCAJADA JP, PUMAROLA T, MARTINEZ JA, TAPIAS G, BAYAS JM, DE LA PRADA M et al. A nosocomial outbreak of influenza during a period without influenza epidemic activity. Eur Respir J 2003; 21: 303-307.
https://doi.org/10.1183/09031936.03.00040503
92. MOSER MR, BENDER TR, MARGOLIS HS, NOBLE GR, KENDAL AP, RITTER DG. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979; 110: 1-6.
https://doi.org/10.1093/oxfordjournals.aje.a112781
93. BEAN B, MOORE BM, STERNER B, PETERSON LR, GERDING DN, BALFOUR HH, JR. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982; 146: 47-51.
https://doi.org/10.1093/infdis/146.1.47
94. VOIRIN N, BARRET B, METZGER MH, VANHEMS P. Hospital-acquired influenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement. J Hosp Infect 2009; 71: 1-14.
https://doi.org/10.1016/j.jhin.2008.08.013
95. CASAS I, EIROS JM, ORTIZ DE LEJARAZU R, PÉREZ P, POZO F, RUIZ G. Procedimientos en Microbiología Clínica. Diagnóstico microbiológico de las infecciones por virus respiratorios. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Procedimiento 29 2ª Edición. 2008. Disponible en http: //www.seimc.org/documentos/protocolos/microbiología/.
96. PACHUCKI CT, PAPPAS SA, FULLER GF, KRAUSE SL, LENTINO JR, SCHAAFF DM. Influenza A among hospital personnel and patients. Implications for recognition, prevention, and control. Arch Intern Med 1989; 149: 77-80.
https://doi.org/10.1001/archinte.1989.00390010091010
97. AOKI FY, BOIVIN G, ROBERTS N. Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther 2007; 12: 603-616.
https://doi.org/10.1177/135965350701200S04.1
98. NICHOL KL, NORDIN JD, NELSON DB, MULLOOLY JP, HAK E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357: 1373-1381.
https://doi.org/10.1056/NEJMoa070844
99. POTTER J, STOTT DJ, ROBERTS MA, ELDER AG, O'DONNELL B, KNIGHT PV et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175: 1-6.
https://doi.org/10.1093/infdis/175.1.1
100. MOISIUK SE, ROBSON D, KLASS L, KLIEWER G, WASYLIUK W, DAVI M et al. Outbreak of parainfluenza virus type 3 in an intermediate care neonatal nursery. Pediatr Infect Dis J 1998; 17: 49-53.
https://doi.org/10.1097/00006454-199801000-00011
101. BRIDGES CB, FUKUDA K, COX NJ, SINGLETON JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001; 50: 1-44.
102. CUNNEY RJ, BIALACHOWSKI A, THORNLEY D, SMAILL FM, PENNIE RA. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2000; 21: 449-454.
https://doi.org/10.1086/501786
103. LARSEN RA, JACOBSON JT, JACOBSON JA, STRIKAS RA, HIERHOLZER JC. Hospital-associated epidemic of pharyngitis and conjunctivitis caused by adenovirus (21/H21 + 35). J Infect Dis. 1986; 154: 706-709.
https://doi.org/10.1093/infdis/154.4.706
104. PINGLETON SK, PINGLETON WW, HILL RH, DIXON A, SOBONYA RE, GERTZEN J. Type 3 adenoviral pneumonia occurring in a respiratory intensive care unit. Chest. 1978; 73: 554-555.
https://doi.org/10.1378/chest.73.4.554
105. BRYANT RE, RHOADES ER. Clinical features of adenoviral pneumonia in Air Force recruits. Am Rev Respir Dis 1967; 96: 717-723.
106. DUDDING BA, WAGNER SC, ZELLER JA, GMELICH JT, FRENCH GR, TOP FH, JR. Fatal pneumonia associated with adenovirus type 7 in three military trainees. N Engl J Med 1972; 286: 1289-1292.
https://doi.org/10.1056/NEJM197206152862403
107. ZAHRADNIK JM. Adenovirus pneumonia. Semin Respir Infect 1987; 2: 104-111.
108. VAN DEN HOOGEN BG, DE JONG JC, GROEN J, KUIKEN T, DE GROOT R, FOUCHIER RA et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-724.
109. WILLIAMS JV, WANG CK, YANG CF, TOLLEFSON SJ, HOUSE FS, HECK JM et al. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 2006; 193: 387-395.
https://doi.org/10.1086/499274
110. VAN DEN HOOGEN BG, HERFST S, SPRONG L, CANE PA, FORLEO-NETO E, DE SWART RL et al. Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 2004; 10: 658-666.
https://doi.org/10.3201/eid1004.030393
111. KAHN JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006; 19: 546-557.
https://doi.org/10.1128/CMR.00014-06
112. KIM S, SUNG H, IM HJ, HONG SJ, KIM MN. Molecular epidemiological investigation of a nosocomial outbreak of human metapneumovirus infection in a pediatric hemato-oncology patient population. J Clin Microbiol 2009; 47: 1221-1224.
https://doi.org/10.1128/JCM.01959-08
113. VON LINSTOW ML, EUGEN-OLSEN J, KOCH A, WINTHER TN, WESTH H, HOGH B. Excretion patterns of human metapneumovirus and respiratory syncytial virus among young children. Eur J Med Res 2006 30; 11: 329-335.
114. TE WIERIK MJ, NGUYEN DT, BEERSMA MF, THIJSEN SF, HEEMSTRA KA. An outbreak of severe respiratory tract infection caused by human metapneumovirus in a residential care facility for elderly in Utrecht, the Netherlands, January to March 2010. Euro Surveill 2012; 17(13).
https://doi.org/10.2807/ese.17.13.20132-en
115. DEGAIL MA, HUGHES GJ, MAULE C, HOLMES C, LILLEY M, PEBODY R et al. A human metapneumovirus outbreak at a community hospital in England, July to September 2010. Euro Surveill 2012; 17(15).
https://doi.org/10.2807/ese.17.15.20145-en
116. JOHNSTONE J, MAJUMDAR SR, FOX JD, MARRIE TJ. Human metapneumovirus pneumonia in adults: results of a prospective study. Clin Infect Dis 2008; 46: 571-574.
https://doi.org/10.1086/526776
117. WALSH EE, PETERSON DR, FALSEY AR. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med 2008; 168: 2489-2496.
https://doi.org/10.1001/archinte.168.22.2489
118. BOIVIN G, ABED Y, PELLETIER G, RUEL L, MOISAN D, COTE S et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002; 186: 1330-1334.
https://doi.org/10.1086/344319
119. BOIVIN G, DE SERRES G, HAMELIN ME, COTE S, ARGOUIN M, TREMBLAY G et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 2007; 44: 1152-1158.
https://doi.org/10.1086/513204
120. LOUIE JK, SCHNURR DP, PAN CY, KIANG D, CARTER C, TOUGAW S et al. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J Infect Dis 2007; 196: 705-708.
https://doi.org/10.1086/519846
121. PITOISET C, DARNIOT M, HUET F, AHO SL, POTHIER P, MANOHA C. Human metapneumovirus genotypes and severity of disease in young children (n = 100) during a 7-year study in Dijon hospital, France. J Med Virol 2010; 82: 1782-1789.
https://doi.org/10.1002/jmv.21884
122. POLAND GA, NICHOL KL. Medical students as sources of rubella and measles outbreaks. Arch Intern Med 1990; 150: 44-46.
https://doi.org/10.1001/archinte.1990.00390130060005
123. Two measles outbreaks after importation--Utah, March-June 2011. MMWR Morb Mortal Wkly Rep 2013; 62: 222-225.
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
